I am a receptor pharmacologist/structural biologist interested in how physiologically-active molecules cause clinical benefits in humans. I have focused on G protein-coupled receptors (GPCRs) and their ligand/drug interactions. My current research is focused on developing advanced peptide analogs targeting amylin receptors.